Early studies have shown that Berberine inhibited the activation of the Notch/snail signaling pathway and upregulated α-SMA and E-cadherin levels in the DKD models, thus inhibiting renal tubular epithelial-mesenchymal transition (EMT) and renal fibrosis [96]. The gene discussed is CDH1; the disease is diabetic kidney disease.